These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12492745

  • 21. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 22. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
    Brunner G, Harke U.
    Aliment Pharmacol Ther; 1994 Oct; 8 Suppl 1():59-64. PubMed ID: 8180296
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
    Corinaldesi R, Valentini M, Belaïche J, Colin R, Geldof H, Maier C.
    Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
    [Abstract] [Full Text] [Related]

  • 25. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE, Bochenek W.
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
    Chen TS, Chang FY, Ng WW, Lee FY, Hwang SJ, Lee SD.
    Hepatogastroenterology; 1999 Nov; 46(28):2372-8. PubMed ID: 10522000
    [Abstract] [Full Text] [Related]

  • 28. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U, Abucar A, Hameeteman W, Schneider A, Stockbrügger RW.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.
    Madrazo-de la Garza A, Dibildox M, Vargas A, Delgado J, Gonzalez J, Yañez P.
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):261-5. PubMed ID: 12548064
    [Abstract] [Full Text] [Related]

  • 31. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD, Van Rensburg C.
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
    [Abstract] [Full Text] [Related]

  • 32. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
    Schepp W, Classen M.
    Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
    [Abstract] [Full Text] [Related]

  • 33. [Superiority of pantoprazole over ranitidine in the treatment of duodenal ulcer. Mexican clinical experience. Mexican Study Group of Pantoprazole++ in Duodenal Ulcer].
    Dibildox M, Rose K, Tomás-Pons J, Fischer R, Gallo S.
    Rev Gastroenterol Mex; 1996 Jun; 61(3):193-8. PubMed ID: 9102740
    [Abstract] [Full Text] [Related]

  • 34. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.
    Mössner J, Hölscher AH, Herz R, Schneider A.
    Aliment Pharmacol Ther; 1995 Jun; 9(3):321-6. PubMed ID: 7654895
    [Abstract] [Full Text] [Related]

  • 35. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 36. A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, Wallner G, Juergens H, Preiksaitis H, Keeling N, Nauclér E, Eklund S, Expo Study Investigators.
    Aliment Pharmacol Ther; 2005 Mar 15; 21(6):739-46. PubMed ID: 15771760
    [Abstract] [Full Text] [Related]

  • 37. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
    Judmaier G, Koelz HR.
    Aliment Pharmacol Ther; 1994 Feb 15; 8(1):81-6. PubMed ID: 8186350
    [Abstract] [Full Text] [Related]

  • 38. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
    Vcev A, Begić I, Ostojić R, Jurcić D, Bozić D, Soldo I, Gmajnić R, Kondza G, Khaznadar E, Mićunović N.
    Coll Antropol; 2006 Sep 15; 30(3):519-22. PubMed ID: 17058517
    [Abstract] [Full Text] [Related]

  • 39. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
    Meneghelli UG, Zaterka S, de Paula Castro L, Malafaia O, Lyra LG.
    Am J Gastroenterol; 2000 Jan 15; 95(1):62-6. PubMed ID: 10638560
    [Abstract] [Full Text] [Related]

  • 40. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Jan 15; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.